NIOX Group (LON:NIOX) Trading Down 0.6% – Should You Sell?

NIOX Group Plc (LON:NIOX) shares were down 0.6% on Thursday . The company traded as low as GBX 67.55 and last traded at GBX 68.20. Approximately 202,489 shares changed hands during mid-day trading, a decline of 76% from the average session volume of 831,375 shares. The stock had previously closed at GBX 68.60.

NIOX Group Stock Down 0.6%

The stock’s fifty day moving average price is GBX 61.63 and its 200 day moving average price is GBX 61.16. The stock has a market cap of £287.03 million, a P/E ratio of 41.59 and a beta of 0.92. The company has a current ratio of 3.81, a quick ratio of 1.94 and a debt-to-equity ratio of 1.36.

Insider Buying and Selling at NIOX Group

In related news, insider Sarah Duncan sold 33,916 shares of the stock in a transaction dated Friday, May 29th. The stock was sold at an average price of GBX 59, for a total transaction of £20,010.44. Company insiders own 5.11% of the company’s stock.

NIOX Group Company Profile

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.